r3
R3 China PR Scope: 43% of in-house PR and marketing teams had integration last year
R3’s seventh China PR Scope Study found that 43% of marketing and PR teams of over 100 brands in China experienced integration in the past year. Get all the details here.
Global forecast: Pharma and healthcare brands shift their ad strategies
Campaign explores how pharma and healthcare brands project the year ahead in spend and media channels—particularly in these trying economic times.
Global forecast: The impact of the energy crisis on adland
Q4 2022: As energy prices skyrocket and half the world enters a third winter with Covid, Campaign explores how brands are investing in and adopting new advertising strategies in the face of an impending recession.
Campaign CMO Outlook: Is the metaverse a fad or here to stay?
In this second part of the 2022 CMO Outlook report, Campaign uncovers how chief marketing officers view a new form of digital advertising; metaverse-based marketing. Meanwhile, marketers also reveal their latest thoughts on talent and on agency partnerships.
.jpeg&h=268&w=401&q=100&v=20170226&c=1)
APAC New Business League: September 2022 report
Dentsu, Wunderman Thompson, OMD and Dentsu X are among the agencies shifting positions in R3's latest tally of APAC new business. Plus, see the top 10 APAC wins.
Half of chief marketers say unproven ROI is biggest obstacle to metaverse
The Campaign survey showed senior marketers are split when it comes to investing in the space.
Top news, insights and analysis every weekday
Sign up for Campaign Bulletins
.jpg&h=334&w=500&q=100&v=20170226&c=1)
